Furthermore, IL-17 has been shown to selectively enhance the production of angiogenic chemokines such as CXCL1, CXCL5, CXCL6, and CXCL8 in tumor cells and epithelial cells (Numasaki et al., 2005; Lee et al., 2008). This evidence concerns the gene IL17A and neoplasm.